ARTICLE | Clinical News
MORAb-004 regulatory update
June 13, 2011 7:00 AM UTC
FDA granted Orphan Drug designation for MORAb-004 from Eisai's Morphotek Inc. subsidiary to treat soft tissue sarcoma (STS). The humanized IgG mAb against CD248 endosialin (TEM1) is in Phase I testi...